Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hamos, J. E.
Right arrow Articles by Drachman, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hamos, J. E.
Right arrow Articles by Drachman, D. A.
NEUROLOGY 1989;39:355
© 1989 American Academy of Neurology

Synaptic loss in Alzheimer's disease and other dementias

James E. Hamos, PhD, Louis J. DeGennaro, PhD and David A. Drachman, MD

Department of Neurology, University of Massachusetts Medical Center, Worcester, MA.

The extent and location of neuronal losses necessary or sufficient to produce dementia in patients with Alzheimer's Disease (AD) is unknown. To approach this question, we studied synaptic terminals in postmortem brain tissue utilizing immunohistochemical techniques. We used antibodies against two proteins found in synaptic terminals—synapsin I and synaptophysin—as synaptic markers in the hippocampal complexes of eight patients with autopsy-proven AD and eight nondemented control subjects. Quantitative microscopy measured the regional density of synaptic staining. All AD patients showed a striking decrease in synaptic staining in the outer half of the molecular layer of the dentate gyrus compared with control brains, where the density of synaptic terminals was uniform throughout. In an additional patient with progressive degenerative dementia but without plaques or tangles on neuropathologic examination, similar depletion of synaptic staining was seen in the dentate gyrus. Quantitative densitometric analyses confirmed the focal decrease in synaptic staining in the outer half of the molecular layer in demented patients. We also found a slight increase in synaptic staining in the inner half of this layer.

Address correspondence and reprint requests to Dr. Hamos, Department of Neurology, University of Massachusetts Medical Center, 55 Lake Avenue North, Worcester, MA 01655.

Supported in part by grants from the Massachusetts Department of Public Health, the Massachusetts Alzheimer's Disease Research Center (NIA grant P50 AG05134), the Sterling Morton Research Fund, and the Stanley and Harriet Friedman Research Fund.

Presented in part at the fortieth annual meeting of the American Academy of Neurology, Cincinnati, OH, April 1988.

Received July 22, 1988. Accepted for publication in final form September 29, 1988.




This article has been cited by other articles:


Home page
AM J ALZHEIMERS DIS OTHER DEMENHome page
G. J. Revuelta, A. Rosso, and C. F. Lippa
Neuritic Pathology as a Correlate of Synaptic Loss in Dementia With Lewy Bodies
American Journal of Alzheimer's Disease and Other Dementias, March 1, 2008; 23(1): 97 - 102.
[Abstract] [PDF]


Home page
J. Neurosci.Home page
J. H. Chin, L. Ma, D. MacTavish, and J. H. Jhamandas
Amyloid {beta} Protein Modulates Glutamate-Mediated Neurotransmission in the Rat Basal Forebrain: Involvement of Presynaptic Neuronal Nicotinic Acetylcholine and Metabotropic Glutamate Receptors
J. Neurosci., August 29, 2007; 27(35): 9262 - 9269.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Bandyopadhyay, G. Li, H. Yin, and J. Kuret
Tau Aggregation and Toxicity in a Cell Culture Model of Tauopathy
J. Biol. Chem., June 1, 2007; 282(22): 16454 - 16464.
[Abstract] [Full Text] [PDF]


Home page
AM J ALZHEIMERS DIS OTHER DEMENHome page
K. Haleem, C. F. Lippa, T. W. Smith, H. Kowa, Jianlin Wu, and T. Iwatsubo
Presenilin-1 C410Y Alzheimer Disease Plaques Contain Synaptic Proteins
American Journal of Alzheimer's Disease and Other Dementias, April 1, 2007; 22(2): 137 - 144.
[Abstract] [PDF]


Home page
AM J ALZHEIMERS DIS OTHER DEMENHome page
C. F. Lippa
An Individualized Approach to Treatment for Alzheimer's Disease, Pick's Disease, and Other Dementias.
American Journal of Alzheimer's Disease and Other Dementias, October 1, 2006; 21(5): 354 - 359.
[Abstract] [PDF]


Home page
AM J ALZHEIMERS DIS OTHER DEMENHome page
C. F. Lippa
Synaptophysin immunoreactivity in Pick's disease: Comparison with Alzheimer's disease and dementia with Lewy bodies
American Journal of Alzheimer's Disease and Other Dementias, November 1, 2004; 19(6): 341 - 344.
[Abstract] [PDF]


Home page
Am. J. Pathol.Home page
H.-g. Lee, P. I. Moreira, X. Zhu, M. A. Smith, and G. Perry
Staying Connected: Synapses in Alzheimer Disease
Am. J. Pathol., November 1, 2004; 165(5): 1461 - 1464.
[Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
J-C Mwanza, L K Nyamabo, T Tylleskar, and G T Plant
Neuro-ophthalmological disorders in HIV infected subjects with neurological manifestations
Br. J. Ophthalmol., November 1, 2004; 88(11): 1455 - 1459.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
P. Coleman, H. Federoff, and R. Kurlan
A focus on the synapse for neuroprotection in Alzheimer disease and other dementias
Neurology, October 12, 2004; 63(7): 1155 - 1162.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
K. L. Davis, D. G. Stewart, J. I. Friedman, M. Buchsbaum, P. D. Harvey, P. R. Hof, J. Buxbaum, and V. Haroutunian
White Matter Changes in Schizophrenia: Evidence for Myelin-Related Dysfunction
Arch Gen Psychiatry, May 1, 2003; 60(5): 443 - 456.
[Abstract] [Full Text] [PDF]


Home page
AM J ALZHEIMERS DIS OTHER DEMENHome page
B. Mehring, J. C.Y. Lin, D. Wilson, and C. F. Lippa
Frontotemporal dementia with ubiquitinated inclusions: A case study of the regional distribution of hippocampal pathology
American Journal of Alzheimer's Disease and Other Dementias, September 1, 2000; 15(5): 277 - 283.
[Abstract] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. E. Donahue, T. M. Berzin, M. S. Rafii, D. J. Glass, G. D. Yancopoulos, J. R. Fallon, and E. G. Stopa
Agrin in Alzheimer's disease: Altered solubility and abnormal distribution within microvasculature and brain parenchyma
PNAS, May 25, 1999; 96(11): 6468 - 6472.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
L. H. Kuller, L. Shemanski, T. Manolio, M. Haan, L. Fried, N. Bryan, G. L. Burke, R. Tracy, and R. Bhadelia
Relationship Between ApoE, MRI Findings, and Cognitive Function in the Cardiovascular Health Study
Stroke, February 1, 1998; 29(2): 388 - 398.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. L. Oster-Granite, D. L. McPhie, J. Greenan, and R. L. Neve
Age-Dependent Neuronal and Synaptic Degeneration in Mice Transgenic for the C Terminus of the Amyloid Precursor Protein
J. Neurosci., November 1, 1996; 16(21): 6732 - 6741.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
T. Gomez-Isla, J. L. Price, D. W. McKeel Jr., J. C. Morris, J. H. Growdon, and B. T. Hyman
Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer''s Disease
J. Neurosci., July 15, 1996; 16(14): 4491 - 4500.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. M. Kajkowski, C. F. Lo, X. Ning, S. Walker, H. J. Sofia, W. Wang, W. Edris, P. Chanda, E. Wagner, S. Vile, et al.
beta -Amyloid Peptide-induced Apoptosis Regulated by a Novel Protein Containing a G Protein Activation Module
J. Biol. Chem., May 25, 2001; 276(22): 18748 - 18756.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by AAN Enterprises, Inc.